This invention is software that enhances the usability of Lucid Inc. for the purpose of using their Vivascope devices for assessment of Meissner Corpuscle density as a measure of sensory neuropathies.
Applications:
This software has significantly enabled quantization of Meissner Corpuscles by markedly decreasing the time required for assembly of images for Meissner corpuscles analysis and also by simplifying and semi-automating counts and morphologic and morphometric assessments of Meissner Corpuscles. This software will enable Meissner corpuscle density assessment as a measure of various sensory neuropathies including from HIV infection, diabetes and inherited neuropathies such as Charcot Marie Tooth Neuropathy.